A systems chemical biology approach to characterize beneficial off-target effects revealed a polypharmacology mechanism for the multikinase inhibitor ceritinib and a repurposing opportunity through rational design of a synergistic drug combination.
- Brent M Kuenzi
- Lily L Remsing Rix
- Uwe Rix